Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
In this comprehensive guide, we examine the clinical evidence behind the tirzepatide therapy and testosterone connection, who benefits most from combining these therapies, and what to expect from treatment
Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science
In reality, semaglutide medications are considered a tool and not an easy, catch-all solution
VAL-databaserna Region Stockholm
Sensitivity of KRAS mutant colorectal cancers to combination therapy that co-targets MEK and CDK4/6
A sensitivity analysis excluding the ITCA trial yielded consistent results (HR (95%CI): 0.85 (0.770.94)
US$ 20.53
US$ 25.04
US$ 20.62
US$ 29.49
US$ 23.27
US$ 25.54
